The Mexico Asthma and COPD Therapeutics Market was valued at US $501 Mn in 2022, and is predicted to grow at (CAGR) of 5.45% from 2023 to 2030, to US $766 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of COPD and asthma, increasing demand, supportive policies, and others. The industry is primarily dominated by players such as, GlaxoSmithKline, Tetherex, Novartis, AstraZeneca, Verona, and Boehringer Ingelheim, among others
The Mexico Asthma and COPD Therapeutics Market is at around US $501 Mn in 2022 and is projected to reach US $766 Mn in 2030, exhibiting a CAGR of 5.45% during the forecast period.
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are persistent respiratory conditions that impact the airways, resulting in difficulties breathing. Asthma is characterized by inflammation and narrowing of the airways, often triggered by allergens, irritants, or physical activity. Common symptoms include wheezing, shortness of breath, chest tightness, and coughing, with risk factors such as a family history and respiratory infections. COPD encompasses chronic bronchitis and emphysema, leading to obstructed airways, with smoking identified as a primary risk factor. Observable COPD symptoms include a lingering cough, increased mucus production, and fatigue. Treatment for both asthma and COPD involves the use of bronchodilators to alleviate airway constriction and anti-inflammatory medications to address inflammation. Pharmaceuticals manufactured by companies like GlaxoSmithKline, AstraZeneca, and Boehringer Ingelheim are commonly prescribed for these conditions. Ongoing advancements in therapeutic approaches for asthma and COPD focus on innovative anti-inflammatory agents, bronchodilators, and targeted therapies.
COPD affects around 9% of the population, whereas the prevalence of asthma ranges from 6% to 8% across age groups 6–15 in Mexico. These estimates are closely linked to high rates of smoking, air pollution, and occupational exposures within the population. The primary factors driving the market are the increase in the aging population and the subsequent rise in asthma and COPD, demand for effective therapeutics, and supportive government policies. However, high costs of advanced treatment, limited access to healthcare, and limited public awareness are a few factors that limit the market's potential.
Market Growth Drivers
Surge in prevalence: The prevalence of COPD in Mexico is estimated to be approximately 9% in the age group 35 years and above. Subsequently, the prevalence of asthma is estimated to be around 6% in the age group 6-7 years and around 7.5% in children between 13 and 15 years. The contributing factors include elevated smoking rates, air pollution, and occupational exposures. The growing elderly population in Mexico is becoming more vulnerable to chronic respiratory conditions like COPD. The rising patient population leads to the growth of the market.
Growing demand for effective medications: Current medications for asthma and COPD frequently face limitations related to side effects, adherence, and long-term efficacy. This creates a need for new and more precisely targeted therapies. Advances in inhaler technology, biologics, and personalized medicine present encouraging possibilities for enhancing the management of these conditions.
Supportive government policies: The rise in government and private healthcare expenditures enables expanded access to advanced medications and treatment choices. Market growth is further fuelled by public health initiatives such as the Global Asthma Network Mexico, which targets increased awareness, enhanced diagnosis, and improved access to treatment.
Market Restraints
Cost of treatment: Inhalers, along with other delivery devices and newer biologic therapies, may pose a financial challenge for a considerable segment of the population, especially those lacking sufficient health insurance. This financial barrier can result in non-adherence to medication regimens and, subsequently, less favourable treatment outcomes.
Limited access to healthcare: The uneven distribution of healthcare facilities and staff, particularly in rural areas, establishes obstacles to access for numerous patients. Extended wait times and difficulties in transportation additionally hinder prompt diagnosis and treatment.
Lack of awareness: A lack of adequate knowledge about asthma and COPD, encompassing their symptoms and management approaches, among both patients and healthcare providers, can result in delays in diagnosis and appropriate treatment. Additionally, the stigma linked to respiratory conditions may discourage individuals from seeking assistance.
Mexico's healthcare policy and regulatory landscape are directed by the Ministry of Health (Secretaría de Salud, or SSA), which serves as the central governing body responsible for crafting and executing health policies at the federal level. The SSA takes on a pivotal role in overseeing healthcare services, ensuring their quality, and addressing public health concerns. Additionally, individual states in Mexico, numbering 32 in total, maintain their own health departments, contributing to the broader healthcare framework while tailoring policies to suit regional requirements.
Securing a healthcare license in Mexico entails a multi-faceted process regulated by diverse authorities. Healthcare professionals, spanning physicians, nurses, and allied health practitioners, typically need to graduate from accredited institutions and successfully pass field-relevant examinations. Oversight related to pharmaceuticals and medical devices is conducted by the Federal Commission for the Protection against Sanitary Risk (Comisión Federal para la Protección contra Riesgos Sanitarios, or COFEPRIS). Licensing for healthcare professionals is often under the purview of specific councils or boards tied to each profession, such as the Mexican Council of General Medicine or the Mexican Nursing Council.
These regulatory entities ensure that healthcare practitioners meet the requisite standards and adhere to ethical and professional guidelines, contributing to the overall safety and quality of healthcare services in Mexico.
Key Players
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Disease Type
By Medication Class
By Delivery Device
By Route of Administration
By End User
By Distribution Channel
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?